Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Director comp.
CC transcript
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPDI) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/05/2011 8-K Quarterly results
11/07/2011 8-K Form 8-K - Current report
10/03/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Pharmaceutical Product Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc",
"PPD to be Acquired by The Carlyle Group and Hellman & Friedman"
09/22/2011 8-K Appointed a new director
Docs: "PPD Appoints Raymond Hill as Chief Executive Officer and Member of the Board of Directors"
07/26/2011 8-K Quarterly results
Docs: "PPD Reports Second Quarter 2011 Financial Results"
07/18/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PPD Comments on Recent Stock Market Developments"
05/19/2011 8-K Form 8-K - Current report
04/26/2011 8-K Form 8-K - Current report
02/24/2011 8-K Form 8-K - Current report
02/15/2011 8-K Form 8-K - Current report
02/09/2011 8-K Form 8-K - Current report
02/08/2011 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "PPD Reports Fourth Quarter and Full Year 2010 Financial Results"
10/27/2010 8-K/A Form 8-K - Current report [amend]
07/27/2010 8-K Form 8-K - Current report
06/01/2010 8-K Form 8-K - Current report
05/24/2010 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "PPD Sets Record and Distribution Dates for Spin-Off of Furiex Pharmaceuticals"
02/08/2010 8-K Form 8-K - Current report
01/22/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Transcript of PPD's January 20, 2010 conference call"
11/20/2009 8-K Form 8-K - Current report
10/27/2009 8-K Quarterly results
Docs: "PPD Reports Third Quarter 2009 Financial Results; Updates 2009 Financial Guidance"
07/22/2009 8-K Quarterly results
Docs: "PPD Reports Second Quarter 2009 Financial Results Second Quarter Highlights: • Diluted EPS of $0.49, including $0.16 gain on sale of Piedmont Research Center, LLC • Continued strong margin delivery • Priligy ® royalties commence"
06/26/2009 8-K/A Form 8-K - Current report [amend]
05/22/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "6",
"6",
"6",
"shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing"
04/22/2009 8-K Form 8-K -- Current report
02/09/2009 8-K Form 8-K -- Current report
10/21/2008 8-K Quarterly results
Docs: "PPD REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS; UPDATES 2008 FINANCIAL GUIDANCE"
07/25/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Regulation FD Disclos...
Docs: "0",
"shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing"
07/22/2008 8-K Quarterly results
Docs: "PPD REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS"
04/22/2008 8-K Quarterly results
Docs: "PPD REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS"
04/04/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Regulation FD Disclos...
Docs: "Paul Covington to Retire from PPD"
04/02/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Regulation FD Disclos...
Docs: "7",
"shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing"
03/04/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration"
02/22/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "PPD Announces Plan to Repurchase Shares of its Common Stock"
02/06/2008 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "PPD REPORTS FOURTH QUARTER AND YEAR-END 2007 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy